Research
Hormonal contraception and risk of venous thromboembolism: national follow-up study
BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b2890 (Published 13 August 2009) Cite this as: BMJ 2009;339:b2890
Related articles
- Editorial Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b3164
- Editorial Published: 12 October 2010; BMJ 341 doi:10.1136/bmj.c4830
- Paper Published: 13 January 1996; BMJ 312 doi:10.1136/bmj.312.7023.83
- Editorial Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2519
- Research Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2151
- Research Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2139
- Research Published: 16 August 2011; BMJ 343 doi:10.1136/bmj.d4656
- Editorial Published: 25 October 2011; BMJ 343 doi:10.1136/bmj.d6592
- Research Published: 25 October 2011; BMJ 343 doi:10.1136/bmj.d6423
- News Published: 13 December 2011; BMJ 343 doi:10.1136/bmj.d8104
- Research Published: 10 May 2012; BMJ 344 doi:10.1136/bmj.e2990
- Research Published: 12 September 2013; BMJ 347 doi:10.1136/bmj.f5298
- Research Published: 10 May 2016; BMJ 353 doi:10.1136/bmj.i2002
- Student Published: 27 May 2011; BMJ 342 doi:10.1136/sbmj.d3139
- Editorial Published: 14 April 2021; BMJ 373 doi:10.1136/bmj.n958
See more
- The BMJ Appeal 2023-24: Periods don’t stop for disastersBMJ November 30, 2023, 383 p2763; DOI: https://doi.org/10.1136/bmj.p2763
- The “abortion trail” to England from the rest of the British Isles is on rocky groundBMJ November 23, 2023, 383 p2719; DOI: https://doi.org/10.1136/bmj.p2719
- “Two eyed seeing”—embracing both Indigenous and western perspectives in healthcareBMJ November 13, 2023, 383 p2614; DOI: https://doi.org/10.1136/bmj.p2614
- Anastrozole: Repurposed drug could prevent thousands of breast cancer casesBMJ November 07, 2023, 383 p2608; DOI: https://doi.org/10.1136/bmj.p2608
- Maternity care: Dorset County Hospital is downgraded by regulator over poor leadershipBMJ November 02, 2023, 383 p2549; DOI: https://doi.org/10.1136/bmj.p2549
Cited by...
- Thrombosis after covid-19 vaccination
- Womens health in The BMJ: a data science history
- 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- FSRH Guideline (January 2019, amended November 2020) Combined Hormonal Contraception
- Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study
- Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use
- Letter by Rebello et al Regarding Article, "Cryptic Loss of Consciousness in a 36-Year-Old Woman"
- Hormonal Contraceptive Agents: A Need for Pediatric-Specific Studies
- Factors that predict thrombosis in relatives of patients with venous thromboembolism
- Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis
- Impact of UK Medical Eligibility Criteria implementation on prescribing of combined hormonal contraceptives
- Contraception in women over 40 years of age
- Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases
- Contraceptive options for women with SLE
- Risk of venous thromboembolism in oral contraceptive users varies according to progestin type
- Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10
- Long-term tolerability of ethinylestradiol 20 {micro}g/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study
- DTB Select: 1 | January 2012
- Risk of venous thromboembolism with oral contraceptives
- Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study
- The progestogen content of combined oral contraceptives and venous thromboembolic risk
- Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
- Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception
- Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study
- Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel
- Risk of venous thromboembolism with drospirenone-containing oral contraceptives
- Two case-control studies: risk of venous thromboembolism with oral contraceptives
- Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database
- The risk of deep venous thrombosis with oral contraceptives containing drospirenone
- Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data
- Hormonal Contraception and Thrombotic Risk: A Multidisciplinary Approach
- Misleading communication of risk
- Migraine with aura and increased risk of ischaemic stroke
- Great Danes
- With OCs, Hormone Type and Amount Matter for Thrombotic Risk
- Oral contraceptives and venous thromboembolism